推荐阅读

［1］GOMEZ PERDIGUERO E，GEISSMANN F. Cancer immunology.Identifying the infiltrators［J］. Science，2014，344（6186）：801-802.

［2］LAVIN Y，MORTHA A，RAHMAN A，et al. Regulation of macrophage development and function in peripheral tissues［J］. Nat Rev Immunol，2015，15（12）：731-744.

［3］SPRANGER S，DAI D，HORTON B，et al. Tumor-residing batf 3 dendritic cells are required for effector t cell trafficking and adoptive T cell therapy［J］. Cancer Cell，2017，31（5）：711-723.

［4］VIVIER E，RAULET D H，MORETTA A，et al. Innate or adaptive immunity? The example of natural killer cells［J］.Science，2011，331（6013）：44-49.

［5］FRIDMAN W H，PAGÈS F，SAUTÈS-FRIDMAN C，et al.The immune contexture in human tumours：impact on clinical outcome［J］. Nat Rev Cancer，2012，12（4）：298-306.

［6］ANGELL H K，BRUNI D，BARRETT J C，et al. The immunoscore：colon cancer and beyond［J］. Clin Cancer Res，2020，26（2）：332-339.

［7］VAN DEN EYNDE M，MLECNIK B，et al. The link between the multiverse of immune microenvironments in metastases and the survival of colorectal cancer patients［J］. Cancer Cell，2018，34（6）：1012-1026.

［8］BURRELL R A，MCGRANAHAN N，BARTEK J，et al. The causes and consequences of genetic heterogeneity in cancer evolution［J］. Nature，2013，501（7467）：338-345.

［9］ZHANG Y，SONG J，ZHAO Z，et al. Single-cell transcriptome analysis reveals tumor immune microenvironment heterogenicity and granulocytes enrichment in colorectal cancer liver metastases［J］. Cancer Lett，2020，470：84-94.

［10］KALLURI R. The biology and function of fibroblasts in cancer［J］. Nat Rev Cancer，2016，16（9）：582-598.

［11］KOBAYASHI H，ENOMOTO A，WOODS S L，et al. Cancerassociated fibroblasts in gastrointestinal cancer［J］. Nat Rev Gastroenterol Hepatol，2019，16（5）：282-295.

［12］PHNG L K，GERHARDT H. Angiogenesis：a team effort coordinated by notch［J］. Dev Cell，2009，16（2）：196-208.

［13］FERRARA N，GERBER H P，LECOUTER J. The biology of VEGF and its receptors［J］. Nat Med，2003，9（6）：669-676.

［14］BENEDITO R，ROCA C，SÖRENSEN I，et al. The notch ligands Dll4 and Jagged1 have opposing effects on angiogenesis［J］.Cell，2009，137（6）：1124-1135.

［15］DE PALMA M，BIZIATO D，PETROVA T V. Microenvironmental regulation of tumour angiogenesis［J］. Nat Rev Cancer，2017，17（8）：457-474.

［16］MELINCOVICI C S，BOŞCA A B，ŞUŞMAN S，et al. Vascular endothelial growth factor（VEGF）- key factor in normal and pathological angiogenesis［J］. Rom J Morphol Embryol，2018，59（2）：455-467.

［17］QIAN B Z，POLLARD J W. Macrophage diversity enhances tumor progression and metastasis［J］. Cell，2010，141（1）：39-51.

［18］CASSETTA L，POLLARD J W. Targeting macrophages：therapeutic approaches in cancer［J］. Nat Rev Drug Discov，2018，17（12）：887-904.

［19］LEONE R D，POWELL J D. Metabolism of immune cells in cancer［J］. Nat Rev Cancer，2020，20（9）：516-531.